Introduction
The incidence of severe sepsis is increasing within the last decade, reaching 50-100 cases /100.000 people in the general population and approximately 30% in intensive care units. (1, 2) Mortality of patients with sepsis depends on the sepsis stage and co-morbidities. It ranges from 10-20% in patients with uncomplicated sepsis to 20-50% in severe sepsis and up to 80% in patients with septic shock. (1) Admission Acute Physiology, Age, Chronic Health Evaluation (APACHE) II score is a standard predictor of mortality in critically-ill patients, including septic patients. ( 3) It is applicable in the majority of critically-ill patients and extensively validated in several countries due to its simplicity as a predictor of mortality. (4, 5) The score is obtained from the patient's age and the worst values of 12 physiological parameters within the first 24 hours such as body temperature, mean arterial blood pressure, pulse, arterial pO 2 , serum creatinine, potassium, sodium, hematocrit, white blood cell count, Glasgow coma scale, respiratory rate. The higher the APACHE II score, the higher the mortality rate. A variety of other predictors of mortality in patients with sepsis was evaluated in clinical studies, including inflammatory markers such as C-reactive protein (CRP), lactate clearance, cardiac biomarkers such as troponin and ejection fraction (EF), individual organ system failures, presence of multi-organ failure syndrome (MOFS), etc. (6) These studies were performed in heterogeneous patient populations, ranging from lower risk patients with sepsis to high risk septic shock patients, included from wards to surgical or medical intensive care units (ICU). (4) (5) (6) (7) (8) (9) The primary objective of this study was to investigate which patient characteristics are related to outcome in medical patients with severe sepsis or septic shock.
Participants and methods
We performed a retrospective cohort analysis of all adult patients with severe sepsis or septic shock treated in a medical ICU in 2008, 2009 and 2010. The study was approved by the Ehical institutional review board (No. 156/13) and is in accordance with the declaration of Helsinki. In all, 102 patients (63 men, 39 women, mean age 65.1 ± 13.3 years) were included. The criteria for severe sepsis were fulfilled if in patients with sepsis there was at least one organ failure or a sign of tissue hypoperfusion. In septic shock patients there were signs of sepsis in addition to acute circulatory failure with decreased systolic blood pressure < 90 mm Hg or mean arterial blood pressure < 65 mm Hg without any other known causes in spite of adequate infusion of fluids. (10) Patient treatment followed guideline goals. (11) Adequate oxygenation was established by oxygen delivery with or without mechanical ventilation. Adequate perfusion was established by intravenous infusion of fluids, noradrenalin or dobutamine to reach mean arterial pressure > 65 mm Hg, central venous oxygen saturation (ScvO 2 ) > 70% and urine output > 0.5 ml/kg/h within the first 24 hours. EF < 50%, assessed by echocardiography, confirmed systolic cardiac dysfunction. Infection was controlled with intravenous antibiotics, administered within an hour after prior microbiological samples were withdrawn. Low dose hydrocortisone and insulin were administered if necessary. (11) Vital signs, laboratory test results, ICU treatment characteristics and final out- 
Discussion
We observed that several clinical and laboratory data (admission arterial pH, APACHE II score, peak serum lactate, treatment with noradrenalin, mechanical ventilation and CVVH, fungal infection) were associated significantly with 30-day mortality in our patients with severe sepsis and septic shock. Thirty-day mortality in our patients with severe sepsis and septic shock was 62.7%, which is similar to other studies. Treatment with noradrenalin, mechanical ventilation and CVVH, significantly associated with mortality, pointed to a predictive role of pronounced cardiovascular, respiratory and renal failure for 30-day mortality in severe sepsis.
(1,2) Mean admission APACHE II score as a gold standard for predicting mortality was 29 in our patients, predicting approximately a 67.2% death rate and was associated significantly with 30-day mortality of our septic patients. (3) Regarding microorganisms responsible for infection, gram-negative microorganisms were still dominating and identified in 36.3% of patients in contrast to 28.4% of gram-positive bacteria. According to the data in literature it was not surprising that fungal infections in our severely septic patients were significantly associated with 30-day mortality. (12,13) However, binary logistic regression confirmed that only peak lactate levels significantly and independently predicted 30-day mortality in our septic patients. Increased blood lactate levels in critically-ill patients in general are associated with increased morbidity and mortality. (14, 15) Patients with preserved blood pressure and elevated lactate levels are at increased risk of dying as well. (16, 17) The importance of lactate levels is emphasized in the treatment of sepsis, where some treatment strategies as well as mortality risk depend on lactate levels. (11) A variety of other predictors of mortality have been evaluated in clinical studies, including inflammatory markers such as CRP, lactate clearance, cardiac biomarkers such as troponin and ejection fraction, multiorgan failure syndrome, etc. (4-9) Lactic acidosis is common in patients with severe sepsis or septic shock. The pathophysiology of lactic acidosis associated with sepsis is not fully understood. Both increased lactate production during anerobic and aerobic metabolism and decreased clearance likely contribute to hyperlactemia. (18, 19) Lactate-to-pyruvate ratio is elevated 
